The latest update is out from Petros Pharmaceuticals ( (PTPI) ).
John Shulman and Greg Bradley, both members of the board of directors at Petros Pharmaceuticals, Inc., have recently stepped down from their positions. Their resignations, effective October 1 and 2, 2024, respectively, were not due to any disputes or disagreements with the company’s management or business protocols. This change in the company’s leadership could be of interest to stakeholders and market watchers tracking corporate governance and stability.
See more insights into PTPI stock on TipRanks’ Stock Analysis page.
